NO20075152L - Mellomprodukter for fremstilling av trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-C]pyrrol - Google Patents
Mellomprodukter for fremstilling av trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-C]pyrrolInfo
- Publication number
- NO20075152L NO20075152L NO20075152A NO20075152A NO20075152L NO 20075152 L NO20075152 L NO 20075152L NO 20075152 A NO20075152 A NO 20075152A NO 20075152 A NO20075152 A NO 20075152A NO 20075152 L NO20075152 L NO 20075152L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- oxepino
- dibenz
- pyrrole
- tetrahydro
- Prior art date
Links
- VSWBSWWIRNCQIJ-HUUCEWRRSA-N (S,S)-asenapine Chemical compound O1C2=CC=CC=C2[C@H]2CN(C)C[C@@H]2C2=CC(Cl)=CC=C21 VSWBSWWIRNCQIJ-HUUCEWRRSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- 150000003862 amino acid derivatives Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/14—[b,f]-condensed
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05102742 | 2005-04-07 | ||
| PCT/EP2006/061409 WO2006106136A1 (en) | 2005-04-07 | 2006-04-06 | Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20075152L true NO20075152L (no) | 2007-11-01 |
Family
ID=35511130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20075152A NO20075152L (no) | 2005-04-07 | 2007-10-10 | Mellomprodukter for fremstilling av trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-C]pyrrol |
Country Status (27)
| Country | Link |
|---|---|
| EP (2) | EP2154134B1 (de) |
| JP (1) | JP2008534657A (de) |
| KR (1) | KR20070116973A (de) |
| CN (2) | CN101175741B (de) |
| AR (1) | AR063188A1 (de) |
| AT (1) | ATE447564T1 (de) |
| AU (1) | AU2006231281B2 (de) |
| BR (1) | BRPI0610677A2 (de) |
| CA (1) | CA2603181A1 (de) |
| CY (1) | CY1109722T1 (de) |
| DE (1) | DE602006010132D1 (de) |
| DK (1) | DK1710241T3 (de) |
| ES (1) | ES2333980T3 (de) |
| HR (1) | HRP20100031T1 (de) |
| IL (1) | IL186354A0 (de) |
| MX (1) | MX2007012446A (de) |
| NO (1) | NO20075152L (de) |
| NZ (1) | NZ562125A (de) |
| PL (1) | PL1710241T3 (de) |
| PT (1) | PT1710241E (de) |
| RS (1) | RS51341B (de) |
| RU (1) | RU2397164C2 (de) |
| SI (1) | SI1710241T1 (de) |
| TW (1) | TW200716589A (de) |
| UA (2) | UA93044C2 (de) |
| WO (1) | WO2006106136A1 (de) |
| ZA (2) | ZA200708493B (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5027477B2 (ja) * | 2005-10-21 | 2012-09-19 | 住友化学株式会社 | ジベンゾオキセピノピロール化合物およびその中間体の製造方法ならびに新規中間体 |
| TW200817414A (en) * | 2006-07-05 | 2008-04-16 | Organon Nv | Process for the preparation of asenapine and intermediate products used in said process |
| WO2008078482A1 (ja) * | 2006-12-22 | 2008-07-03 | Sumitomo Chemical Company, Limited | アセナピン合成中間体の製造方法 |
| US7875729B2 (en) | 2007-01-05 | 2011-01-25 | Synthon Bv | Process for making asenapine |
| JP5245428B2 (ja) * | 2007-07-06 | 2013-07-24 | 住友化学株式会社 | トランス−ジベンゾオキセノピロール化合物の製造方法およびその中間体 |
| WO2009087058A1 (en) * | 2008-01-04 | 2009-07-16 | N.V. Organon | Process for the preparation of asenapine and intermediate products used in said process |
| BRPI1011453A2 (pt) * | 2009-06-24 | 2016-03-15 | Msd Oss Bv | formulacao, forma de dosagem de um medicamento, e, sal de hemipamoato de asenapina |
| CN101851242B (zh) * | 2010-05-25 | 2013-07-24 | 上海皓元生物医药科技有限公司 | 阿塞那平中间体的制备方法 |
| CA2805542C (en) | 2010-07-29 | 2017-12-12 | Inke S.A. | Novel process for the preparation of asenapine |
| WO2012038975A2 (en) * | 2010-09-22 | 2012-03-29 | Msn Laboratories Limited | Process for the preparation of (3ars,12brs)-5-chloro-2-methyl-2,3,3a12b-tetrahydro-1hdibenzo[2,3:6,7] oxepino [4,5-c]pyrrole maleate and it's pharmaceutical composition thereof |
| EP2468751B1 (de) | 2010-12-24 | 2016-03-16 | Medichem, S.A. | Verfahren zur Herstellung von 5-Chlor-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol |
| ITMI20110734A1 (it) * | 2011-05-02 | 2012-11-03 | Olon Spa | Sali cristallini di asenapina |
| WO2013024492A2 (en) | 2011-07-01 | 2013-02-21 | Megafine Pharma (P) Ltd. | A process for the preparation of asenapine and novel salts thereof |
| CN102952144A (zh) * | 2011-08-29 | 2013-03-06 | 上海华拓医药科技发展股份有限公司 | 阿森纳平马来酸盐的晶型、制备方法及其药物组合物 |
| WO2013080069A1 (en) * | 2011-11-28 | 2013-06-06 | Ranbaxy Laboratories Limited | Process for the preparation of asenapine intermediate |
| CN102746209A (zh) * | 2012-06-20 | 2012-10-24 | 盛世泰科生物医药技术(苏州)有限公司 | 一种3-(2-(4-氯苯氧基)苯基)-1-甲基-2,4-二酮的合成方法 |
| CN103965206A (zh) * | 2013-01-29 | 2014-08-06 | 北京京卫燕康药物研究所有限公司 | 一种阿色纳品马来酸盐的新晶型及制备方法 |
| CN103113379A (zh) * | 2013-03-12 | 2013-05-22 | 盛世泰科生物医药技术(苏州)有限公司 | 阿塞那平马来酸盐的合成工艺 |
| CN103254202A (zh) * | 2013-05-19 | 2013-08-21 | 甘肃皓天化学科技有限公司 | 阿塞纳平的制备方法 |
| CN103342707B (zh) * | 2013-06-28 | 2015-09-02 | 甘肃皓天化学科技有限公司 | 用于制备阿塞纳平中间体的制备方法 |
| CN104447771A (zh) * | 2013-09-12 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 一种稳定的马来酸阿塞那平化合物 |
| CN103864802B (zh) * | 2014-03-31 | 2016-08-17 | 四川科伦药业股份有限公司 | 马来酸阿塞那平的制备方法 |
| CN105693735A (zh) * | 2016-01-15 | 2016-06-22 | 万特制药(海南)有限公司 | 马来酸阿塞那平一种制备方法 |
| CA3047354A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| RU2762896C2 (ru) | 2016-12-20 | 2021-12-23 | Лтс Ломанн Терапи-Систем Аг | Трансдермальная терапевтическая система, содержащая азенапин |
| EP3644973B1 (de) | 2017-06-26 | 2021-03-24 | LTS LOHMANN Therapie-Systeme AG | Transdermales therapeutisches system mit hybridem asenapin- und silikonacrylpolymer |
| CN109200025A (zh) * | 2017-06-29 | 2019-01-15 | 哈尔滨莱博通药业有限公司 | 一种阿森纳平马来酸盐舌下片 |
| CN110958876B (zh) | 2018-06-20 | 2020-12-18 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| CN112533593A (zh) | 2018-06-20 | 2021-03-19 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| CN110183457A (zh) * | 2019-06-27 | 2019-08-30 | 浙江天顺药业有限公司 | 一种阿塞那平及其制备方法 |
| CN112194665A (zh) * | 2020-10-20 | 2021-01-08 | 连云港杰瑞药业有限公司 | 一种合成阿塞那平中间体的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7605526A (nl) * | 1976-05-24 | 1977-11-28 | Akzo Nv | Nieuwe tetracyclische derivaten. |
| CN1079670C (zh) | 1994-03-02 | 2002-02-27 | 阿克佐诺贝尔公司 | 舌下或颊给药的药物组合物 |
| DE59607332D1 (de) * | 1995-02-08 | 2001-08-30 | Novartis Ag | Antineurodegenerativ wirksame 10-Aminoaliphatyl-dibenz- b,f oxepine |
| AU2418499A (en) | 1997-12-19 | 1999-07-12 | Akzo Nobel N.V. | Org-5222 in the treatment of depression |
| US6002632A (en) * | 1998-09-17 | 1999-12-14 | Texas Instruments Incorporated | Circuits, systems, and methods with a memory interface for augmenting precharge control |
| WO2000075127A1 (en) * | 1999-06-03 | 2000-12-14 | Nippon Suisan Kaisha, Ltd. | Tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
-
2006
- 2006-04-06 WO PCT/EP2006/061409 patent/WO2006106136A1/en not_active Ceased
- 2006-04-06 UA UAA200711020A patent/UA93044C2/ru unknown
- 2006-04-06 NZ NZ562125A patent/NZ562125A/en not_active IP Right Cessation
- 2006-04-06 RU RU2007141161/04A patent/RU2397164C2/ru not_active IP Right Cessation
- 2006-04-06 PL PL06112333T patent/PL1710241T3/pl unknown
- 2006-04-06 AU AU2006231281A patent/AU2006231281B2/en not_active Ceased
- 2006-04-06 CN CN2006800167535A patent/CN101175741B/zh not_active Expired - Fee Related
- 2006-04-06 KR KR1020077025399A patent/KR20070116973A/ko not_active Ceased
- 2006-04-06 TW TW095112190A patent/TW200716589A/zh unknown
- 2006-04-06 CN CN2006100916992A patent/CN1861604B/zh active Active
- 2006-04-06 SI SI200630526T patent/SI1710241T1/sl unknown
- 2006-04-06 AT AT06112333T patent/ATE447564T1/de not_active IP Right Cessation
- 2006-04-06 EP EP09174540A patent/EP2154134B1/de active Active
- 2006-04-06 BR BRPI0610677-3A patent/BRPI0610677A2/pt not_active IP Right Cessation
- 2006-04-06 AR ARP060101357A patent/AR063188A1/es unknown
- 2006-04-06 JP JP2008504777A patent/JP2008534657A/ja not_active Withdrawn
- 2006-04-06 CA CA002603181A patent/CA2603181A1/en not_active Abandoned
- 2006-04-06 RS RSP-2010/0014A patent/RS51341B/sr unknown
- 2006-04-06 EP EP06112333A patent/EP1710241B1/de active Active
- 2006-04-06 MX MX2007012446A patent/MX2007012446A/es active IP Right Grant
- 2006-04-06 DK DK06112333.7T patent/DK1710241T3/da active
- 2006-04-06 UA UAA200711019A patent/UA93043C2/ru unknown
- 2006-04-06 ES ES06112333T patent/ES2333980T3/es active Active
- 2006-04-06 PT PT06112333T patent/PT1710241E/pt unknown
- 2006-04-06 DE DE602006010132T patent/DE602006010132D1/de active Active
-
2007
- 2007-10-04 ZA ZA200708493A patent/ZA200708493B/xx unknown
- 2007-10-04 ZA ZA200708490A patent/ZA200708490B/xx unknown
- 2007-10-07 IL IL186354A patent/IL186354A0/en not_active IP Right Cessation
- 2007-10-10 NO NO20075152A patent/NO20075152L/no not_active Application Discontinuation
-
2010
- 2010-01-08 CY CY20101100023T patent/CY1109722T1/el unknown
- 2010-01-18 HR HR20100031T patent/HRP20100031T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20075152L (no) | Mellomprodukter for fremstilling av trans-5-klor-2-metyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oksepino[4,5-C]pyrrol | |
| NO20075142L (no) | krystallformer av asenapinmaleat | |
| BRPI0514925A (pt) | derivados de pirrol[2,3-c]piridina e processos para a preparação destes | |
| NO20071095L (no) | Hittil ukjente tiofenderivater | |
| WO2004056827A3 (en) | Substituted pyrrolo-pyrazole derivatives as kinase inhibitors | |
| MX2007006397A (es) | Derivados de tetrahidropirano. | |
| NO20082511L (no) | Nye pyridopyraziner og deres anvendelse som kinasemodulatorer | |
| TW200500339A (en) | Pyrrolidine derivatives, and process for the preparation | |
| NO20061157L (no) | 4-pyramidonderivater og deres anvendelse som peptidylpeptidmeinbibitorer | |
| IL162461A0 (en) | Polymorphs of clopidogrel hydrogensulfate | |
| WO2005021536A3 (en) | Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors | |
| NO20061363L (no) | Pyrazolo- og imidazo- pyrimidinderivater | |
| WO2008083950A3 (de) | Spirocyclische tetronsäure-derivative | |
| WO2006103277A3 (en) | 2 , 4 , 5-substituted piperidines as renin inhibitors | |
| NO20070550L (no) | Fremgangsmate for fremstilling av pyrrolotriazinforbindelser | |
| WO2005105753A3 (en) | Naphthalimide derivatives, methods for their production and pharmaceutical compositions therefrom | |
| NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater | |
| ATE518858T1 (de) | Pyrroloä3,2-cüpyridinderivate und herstellungsverfahren dafür | |
| DK1838683T3 (da) | Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater | |
| TW200626600A (en) | Octahydropyrrolo[3, 4-c]pyrrole derivatives | |
| DK1501838T3 (da) | Fremgangsmåde til fremstilling af clopidogrel | |
| EA200700550A1 (ru) | Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
| DK1805177T3 (da) | Pyrrolo(3,2-C]pyridinderivater og fremgangsmåde til fremstilling deraf | |
| NO20030801L (no) | Aminoalkenylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte for deres fremstilling og preparater inneholdende de samme | |
| IS8034A (is) | Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |